logo
Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

Chicago Tribune2 days ago
HERMOSILLO, Mexico — The United States' suspension of live cattle imports from Mexico hit at the worst possible time for rancher Martín Ibarra Vargas, who after two years of severe drought had hoped to put his family on better footing selling his calves across the northern border.
Like his father and grandfather before him, Ibarra Vargas has raised cattle on the parched soil of Sonora, the state in northwestern Mexico that shares a long border with the United States, particularly Arizona. His family has faced punishing droughts before but has never before had to contend with the economic hit of a new scourge: the New World Screwworm, a flesh-eating parasite.
U.S. agriculture officials halted live cattle crossing the border in July – the third suspension of the past eight months — due to concerns about the flesh-eating maggot which has been found in southern Mexico and is creeping north.
The screwworm is a larva of the Cochliomyia hominivorax fly that can invade the tissues of any warm-blooded animal, including humans. The parasite enters animals' skin, causing severe damage and lesions that can be fatal. Infected animals are a serious threat to herds.
The U.S. Department of Agriculture calls it a 'devastating pest' and said in June that it poses a threat to 'our livestock industry, our economy, and our food supply chain.' It has embarked on other steps to keep it out of the United States, which eradicated it decades ago.
As part of its strategy the U.S. is preparing to breed billions of sterile flies and release them in Mexico and southern Texas. The aim is for the sterile males to mate with females in the wild who then produce no offspring.
The U.S. ban on live cattle also applies to horses and bison imports. It hit a ranching sector already weakened by drought and specifically a cattle export business that generated $1.2 billion for Mexico last year. This year, Mexican ranchers have exported fewer than 200,000 head of cattle, which is less than half what they historically send in the same period.
For Ibarra Vargas, considered a comparatively small rancher by Sonora's beef-centric standards, the inability to send his calves across the border has made him rethink everything.
The repeated bans on Mexican cows by U.S. authorities has pushed his family to branch into beekeeping, raising sheep and selling cow's milk. What he earns is just a fraction of what he earned by exporting live cattle, but he is trying to hold on through the lean times.
'Tiempos de vacas flacas' — times of the lean cows — as he calls them.
'At least it lets us continue' ranching, the 57-year-old said with a white cowboy hat perched on his head.
Even as ranchers in Sonora intensify their efforts to make sure the parasitic fly never makes it into their state, they've had to seek new markets.
In the past two months, they've sold more than 35,000 mature cows within Mexico at a significant loss.
'We couldn't wait any longer,' said Juan Carlos Ochoa, president of the Sonora Regional Cattle Union. Those sales, he said, came at a '35% lower price difference compared with the export value of a cow.'
That's hard to stomach when beef prices in the U.S. are rising.
The U.S. first suspended cattle imports last November. Since then, more than 2,258 cases of screwworm have been identified in Mexico. Treatment requires a mix of manually removing the maggots, healing the lesions on the cows and using anti-parasite medicine.
Some ranchers have also started retail beef sales through luxury butcher shops referred to as 'meat boutiques.'
There are other foreign markets, for example Japan, but selling vacuum sealed steaks across the Pacific is a dramatically different business than driving calves to U.S. feedlots. The switch is not easy.
With his calves mooing as they ran from one end of a small corral to the other waiting to be fed, Ibarra Vargas said he still hasn't figured out how he will survive an extended period of not being able to send them to the U.S.
The recent two-year drought reduced his cattle stocks and forced him to take on debt to save the small family ranch that has survived for three generations.
Juan Carlos Anaya, director of Agricultural Markets Consulting Group, attributed a 2% drop in Mexico's cattle inventory last year to the drought.
Anaya said Mexican ranchers who export are trying to get the U.S. to separate what happens in southern Mexico from the cattle exporting states in the north where stricter health and sanitation measures are taken, 'but the damage is already done.'
'We're running out of time,' said Ibarra Vargas, who already laments that his children are not interested in carrying on the family business. For a rancher who 'doesn't have a market or money to continue feeding his calves, it's a question of time before he says: 'you know what, this is as far as I go.''
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market
Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market

Business Wire

timea day ago

  • Business Wire

Bayer® Aspirin Introduces Aspirina to the U.S. Pain Market

WHIPPANY, N.J.--(BUSINESS WIRE)--Bayer's Aspirina, the #1 pain relief option in Mexico 1, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. With a deep commitment to Hispanic consumers, Aspirina is poised to provide an accessible and effective solution for pain relief. Bayer's Aspirina, the #1 pain relief option in Mexico, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community. Share As the Hispanic population in the U.S. continues to grow, currently representing 19 percent of the population and projected to reach 28 percent by 2060, Bayer Aspirin recognizes the importance of connecting with this vibrant community. The Aspirina pain relief option resonates deeply with cultural values and family traditions of those from Mexican and Latin American descent who have been using it as a long-standing pain relief option. 'Many Hispanic communities still face inadequate access to healthcare and consumer goods. As the fastest-growing demographic group in the U.S., the Hispanic population presents a unique opportunity for Bayer. By adding Aspirina to the U.S. portfolio, which has a strong equity in LATAM, we are placing the consumer at the center of our strategy. Data shows that 70 percent of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honor and reflect this sentiment,' said Mohamed Atef, Global Brand Lead for Aspirin at Bayer. Many U.S. consumers of Hispanic origin grew up with Bayer's Aspirina— their parents and grandparents relied on it, instilling trust and nostalgia for the brand. Due to those deep connections, Aspirina has a 99 percent awareness rate in Mexico, with 67 percent of consumers using it regularly 2. With this inclusion in the U.S. market, we invite consumers to reconnect with a product that represents reliability, familiarity and their heritage. Bayer invented modern aspirin 125 years ago, and it's the most trusted aspirin brand for pain relief in the U.S. 3 Many pain reliever brands have come and gone over the last century, but Bayer® Aspirin continues to be one of the most trusted pain brands on the market. Aspirina is available at select Walmart and Walgreens, making it easy for families to find the pain relief they know. Join us in celebrating the launch of Aspirina in the U.S. and rediscover a brand that feels like home — a trusted companion in the journey of life. For more information on Aspirina visit About Aspirina For over 125 years, Bayer® Aspirin has been a leading aspirin brand in proven pain relief. Aspirina is a powerful pain reliever and fever reducer that contains 500 mg of the active ingredient aspirin (NSAID*). It provides fast and effective multi-symptom relief of headaches, muscle pain, toothaches, menstrual pain and minor arthritis pain for adults and children over 12, when used as directed. Aspirina is coated to make it easy to swallow and is free of caffeine. *nonsteroidal anti-inflammatory drug About Bayer Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. In line with its mission, 'Health for all, Hunger for none,' the company's products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2023, the Group employed around 100,000 people and had sales of 47.6 billion euros. R&D expenses before special items amounted to 5.8 billion euros. For more information, go to Forward-Looking Statements This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. 1 Based on volume sales in the last 52 weeks, via source: Grupo Knoblock/CID – Centro Integrador de Datos

Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US
Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

Chicago Tribune

time2 days ago

  • Chicago Tribune

Mexican ranchers struggle to adapt as a tiny parasite ravages their cattle exports to the US

HERMOSILLO, Mexico — The United States' suspension of live cattle imports from Mexico hit at the worst possible time for rancher Martín Ibarra Vargas, who after two years of severe drought had hoped to put his family on better footing selling his calves across the northern border. Like his father and grandfather before him, Ibarra Vargas has raised cattle on the parched soil of Sonora, the state in northwestern Mexico that shares a long border with the United States, particularly Arizona. His family has faced punishing droughts before but has never before had to contend with the economic hit of a new scourge: the New World Screwworm, a flesh-eating parasite. U.S. agriculture officials halted live cattle crossing the border in July – the third suspension of the past eight months — due to concerns about the flesh-eating maggot which has been found in southern Mexico and is creeping north. The screwworm is a larva of the Cochliomyia hominivorax fly that can invade the tissues of any warm-blooded animal, including humans. The parasite enters animals' skin, causing severe damage and lesions that can be fatal. Infected animals are a serious threat to herds. The U.S. Department of Agriculture calls it a 'devastating pest' and said in June that it poses a threat to 'our livestock industry, our economy, and our food supply chain.' It has embarked on other steps to keep it out of the United States, which eradicated it decades ago. As part of its strategy the U.S. is preparing to breed billions of sterile flies and release them in Mexico and southern Texas. The aim is for the sterile males to mate with females in the wild who then produce no offspring. The U.S. ban on live cattle also applies to horses and bison imports. It hit a ranching sector already weakened by drought and specifically a cattle export business that generated $1.2 billion for Mexico last year. This year, Mexican ranchers have exported fewer than 200,000 head of cattle, which is less than half what they historically send in the same period. For Ibarra Vargas, considered a comparatively small rancher by Sonora's beef-centric standards, the inability to send his calves across the border has made him rethink everything. The repeated bans on Mexican cows by U.S. authorities has pushed his family to branch into beekeeping, raising sheep and selling cow's milk. What he earns is just a fraction of what he earned by exporting live cattle, but he is trying to hold on through the lean times. 'Tiempos de vacas flacas' — times of the lean cows — as he calls them. 'At least it lets us continue' ranching, the 57-year-old said with a white cowboy hat perched on his head. Even as ranchers in Sonora intensify their efforts to make sure the parasitic fly never makes it into their state, they've had to seek new markets. In the past two months, they've sold more than 35,000 mature cows within Mexico at a significant loss. 'We couldn't wait any longer,' said Juan Carlos Ochoa, president of the Sonora Regional Cattle Union. Those sales, he said, came at a '35% lower price difference compared with the export value of a cow.' That's hard to stomach when beef prices in the U.S. are rising. The U.S. first suspended cattle imports last November. Since then, more than 2,258 cases of screwworm have been identified in Mexico. Treatment requires a mix of manually removing the maggots, healing the lesions on the cows and using anti-parasite medicine. Some ranchers have also started retail beef sales through luxury butcher shops referred to as 'meat boutiques.' There are other foreign markets, for example Japan, but selling vacuum sealed steaks across the Pacific is a dramatically different business than driving calves to U.S. feedlots. The switch is not easy. With his calves mooing as they ran from one end of a small corral to the other waiting to be fed, Ibarra Vargas said he still hasn't figured out how he will survive an extended period of not being able to send them to the U.S. The recent two-year drought reduced his cattle stocks and forced him to take on debt to save the small family ranch that has survived for three generations. Juan Carlos Anaya, director of Agricultural Markets Consulting Group, attributed a 2% drop in Mexico's cattle inventory last year to the drought. Anaya said Mexican ranchers who export are trying to get the U.S. to separate what happens in southern Mexico from the cattle exporting states in the north where stricter health and sanitation measures are taken, 'but the damage is already done.' 'We're running out of time,' said Ibarra Vargas, who already laments that his children are not interested in carrying on the family business. For a rancher who 'doesn't have a market or money to continue feeding his calves, it's a question of time before he says: 'you know what, this is as far as I go.''

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

Yahoo

time3 days ago

  • Yahoo

Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge

The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico's biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-private partnerships, further bolsters this growth. Emerging challenges include high setup costs and complex regulatory requirements, offering opportunities for innovation and collaboration. Mexican Microcarrier Market Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Mexico Microcarrier Market to Reach US$ 77.65 Million by 2033 - 7.66% CAGR Growth Driven by Biopharma Demand" report has been added to Mexico Microcarrier Market is expected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, with a CAGR of 7.66% from 2025 to 2033. Growing investment in regenerative medicine and cell therapy, growing demand for cell-based vaccines and biologics, technological advancements in culture efficiency, and expansion of biopharmaceutical research and development in Mexico. Mexico's growing biopharmaceutical and biotechnology industries depend heavily on the microcarrier industry. The large-scale manufacturing of biologics, vaccines, and cell treatments depends on microcarriers, which are tiny, spherical particles that promote the proliferation of adherent cells in bioreactors. As Mexico looks to improve its local manufacturing capabilities in response to growing healthcare demands and the need for medical product self-sufficiency, these applications become more and more market is expanding due to a number of causes. Research and development expenditures, along with the nation's strategic efforts to strengthen its biomanufacturing infrastructure, are essential. The need for effective cell culture systems is further fueled by the aging population and the rising incidence of chronic diseases, which increase demand for cutting-edge treatment solutions. Additionally, Mexico has easier access to cutting-edge biotechnologies, such as microcarrier-based cell culture systems, thanks to its involvement in international health programs and collaborations with foreign the encouraging growth trajectory, the Mexican microcarrier market still confronts obstacles including the requirement for specialized technological know-how and the development of strong regulatory frameworks to guarantee the quality and safety of the products. Nonetheless, these difficulties offer chances for creativity and cooperation. These problems can be resolved by creating training initiatives, establishing regulatory guidelines, and encouraging public-private partnerships. This will create an atmosphere that is favorable for the expansion of the microcarrier market and the larger biopharmaceutical sector in Factors Driving the Mexico Microcarrier Market Growth Increasing Demand for Cell Therapy and BiopharmaceuticalsMicrocarrier systems are in high demand due to Mexico's growing biopharmaceutical industry, which includes the manufacture of vaccines, biologics, and cell treatments. Businesses are depending more and more on microcarriers to sustain high density adherent cell cultures in bioreactors as local R&D becomes more intense and manufacturing capacity need is particularly noticeable in the creation of therapeutic proteins, monoclonal antibodies, and items related to regenerative medicine. Scalable and effective cell culture is made possible by microcarriers, which is necessary for the commercial production of biologics and sophisticated cell culture systems are now a vital enabling technology for Mexico's biomanufacturing efforts as the nation develops its capacities in these fields and aligns with international health Development and Manufacturing ExpansionMexico's bioprocessing infrastructure is being quickly strengthened through government sponsored initiatives and strategic public-private partnerships. The adoption of effective cell culture technologies is being fueled by investments in upstream bioprocessing facilities, automation, single use systems, and digital technology is also supported by the growth of industry academia partnership and regulatory modernization (e.g., COFEPRIS's digital transformation). These advancements promote easier technology transfer from research to production and improve the technical preparedness required for microcarrier is therefore better able to scale complex bioprocesses, which increases the accessibility of microcarriers for biotechnology companies, contract manufacturers, and academic institutions seeking to increase their capacity for and Technological Progress in MicrocarriersPerformance and scalability have been greatly enhanced by innovations in microcarrier design, such as surface functionalized beads, biodegradable materials, and compatibility with single use bioreactors. Manufacturers who prioritize quality and cost effectiveness are placing a greater value on enhanced features like increased yield, better cell adhesion, and lower contamination developments, when combined with automation, intelligent sensor integration, and digital process control, reduce human error and streamline production. Modern microcarrier formats are becoming feasible choices for biomanufacturers and researchers nation wide due to Mexico's rising alignment with international industry trends and the country's expanding adoption of state of the art bioprocessing in the Mexico Microcarrier Market Expensive Startup and Ongoing CostsMicrocarrier based cell culture system deployment requires a large financial outlay, especially for equipment such as bioreactors, single use systems, and associated infrastructure. Traditional planar culture techniques are still less expensive at lower scales because they require less like microcarrier beads make up a significant portion of the continuous expenses for microcarrier setups, which frequently require tens or even hundreds of thousands of dollars in capital expenditure. GMP grade, high quality microcarriers can account for 20-25% of total consumable financial barriers, in addition to media supplies and labor training, make the technology hard to adopt in Mexico, where a large number of biotech companies and academic institutions have tight budgets. Despite the long term productivity and efficiency benefits of microcarriers, this hinders scale of Regulations and Documentation NeedsUnder the General Health Law, COFEPRIS is in charge of regulating microcarrier based cell culture in Mexico, particularly when it is meant for clinical or therapeutic applications. In accordance with ICH guidelines, businesses are required to compile comprehensive Common Technical Document (CTD) dossiers that include clinical, non clinical, and quality is necessary to adhere to Official Mexican Standards (such as NOM?257?SSA1?2014, NOM?059?SSA1?2015), especially those that deal with GMP, bio comparability, and safety assessment. Microcarrier systems need to be thoroughly validated, which includes testing for batch uniformity, sterility, and cell material obstacles to commercialization include the burden of complicated documentation and testing, changing regulations, and unclear advanced therapeutic standards. Market access may be delayed, more expensive, and unclear for entities without local regulatory partnerships or past dossier experience. Company Analysis: Overview, Key Persons, Recent Developments, SWOT Analysis, Revenue Analysis Thermo Fisher Scientific Merck KGaA Eppendorf AG Danaher Corporation Sartorius AG Bio Rad Laboratories, Inc. Corning Inc. Lonza Group Getinge Becton, Dickinson and Company Key Attributes: Report Attribute Details No. of Pages 200 Forecast Period 2024 - 2033 Estimated Market Value (USD) in 2024 $39.96 Million Forecasted Market Value (USD) by 2033 $77.65 Million Compound Annual Growth Rate 7.6% Regions Covered Mexico Key Topics Covered: 1. Introduction2. Research & Methodology2.1 Data Source2.1.1 Primary Sources2.1.2 Secondary Sources2.2 Research Approach2.2.1 Top-Down Approach2.2.2 Bottom-Up Approach2.3 Forecast Projection Methodology3. Executive Summary4. Market Dynamics4.1 Growth Drivers4.2 Challenges5. Mexico Microcarrier Market5.1 Historical Market Trends5.2 Market Forecast6. Market Share Analysis6.1 By Product Type6.2 By Application6.3 By End User6.4 By Region7. Product Type7.1 Consumables7.1.1 Microcarrier Beads7.1.2 Media & Reagents7.2 Equipment8. Application8.1 Cell Therapy8.1.1 Market Analysis8.1.2 Market Size & Forecast8.2 Vaccine Manufacturing8.3 Others9. End User9.1 Pharmaceutical & Biotechnology Companies9.2 Contract Research Organizations & Contract Manufacturing Organizations9.3 Academic & Research Institutes10. Region10.1 Northern Mexico10.2 Central Mexico10.3 Southern Mexico10.4 Others11. Value Chain Analysis12. Porter's Five Forces Analysis12.1 Bargaining Power of Buyers12.2 Bargaining Power of Suppliers12.3 Degree of Competition12.4 Threat of New Entrants12.5 Threat of Substitutes13. SWOT Analysis13.1 Strength13.2 Weakness13.3 Opportunity13.4 Threats14. Pricing Benchmark Analysis14.1 Thermo Fisher Scientific14.2 Merck KGaA14.3 Eppendorf AG14.4 Danaher Corporation14.5 Sartorius AG14.6 Bio-Rad Laboratories, Inc.14.7 Corning Inc.14.8 Lonza Group14.9 Getinge14.10 Becton, Dickinson and Company15. Key Players Analysis For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Attachment Mexican Microcarrier Market CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store